Australian Business GrantsFinder
Open⚠ Closes 29 April 2026

Cooperative Research Centres (CRC) Grants - Cell Therapy Manufacturing

Funding
Varies
Region
Commonwealth
Closing Date
29 April 2026
View Official Page

Overview

The Cell Therapy Manufacturing Cooperative Research Centre (CTM CRC) is funded by the Australian Government to develop innovative cell therapy manufacturing technologies. The CRC focuses on creating stem cell delivery systems for chronic wound treatment and developing scalable production methods for immune cell therapies used in cancer and other medical conditions.

Eligibility Requirements

This is a Cooperative Research Centre grant supporting collaborative research between public and private sector organisations in cell therapy manufacturing and regenerative medicine.

Who Can Apply

Nonprofit

Relevant Industries

HealthManufacturingResearch

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page
Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants

Open·Commonwealth·From $56,100,000

Cooperative Research Centres (CRC) Program

The CRC Program funds collaborative research between industry, government, and academic partners to develop technologies and solutions for real-world problems. CRC CARE specifically focuses on developing technologies to assess, clean up, and prevent soil, water, and air contamination, with support totaling $56.1 million in Australian Government funding since 2005.

Open·Commonwealth·$100,000 - $3,000,000

Cooperative Research Centres Projects (CRC-P) Grants

CRC-P Grants provide matched funding of $100,000 to $3 million for short-term (up to 3 years) industry-led research collaborations. Projects must develop a product, service or process that solves industry problems and benefits SMEs, with eligible costs including new research, proof of concept, pre-commercialisation, and industry-focused education.

Open·Commonwealth·Up to $150,000,000

Research and Development Tax Incentive (R&DTI)

A legislated tax offset program that supports companies to invest in eligible research and development by offsetting some of the associated costs. The program provides refundable or non-refundable tax offsets based on company turnover and R&D expenditure proportions, with offsets up to $150 million.